vs
Side-by-side financial comparison of OneStream, Inc. (OS) and Twist Bioscience Corp (TWST). Click either name above to swap in a different company.
OneStream, Inc. is the larger business by last-quarter revenue ($163.7M vs $103.7M, roughly 1.6× Twist Bioscience Corp). OneStream, Inc. runs the higher net margin — 0.6% vs -29.4%, a 30.0% gap on every dollar of revenue. On growth, OneStream, Inc. posted the faster year-over-year revenue change (23.6% vs 16.9%). OneStream, Inc. produced more free cash flow last quarter ($25.6M vs $-34.8M).
Blue Stream provides cable television, cable telephone, DVR, and up to 1 GIG Internet speed broadband services to customers in the Florida communities of Coral Springs and Weston.
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
OS vs TWST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $163.7M | $103.7M |
| Net Profit | $999.0K | $-30.5M |
| Gross Margin | 69.8% | 52.0% |
| Operating Margin | -3.2% | -31.7% |
| Net Margin | 0.6% | -29.4% |
| Revenue YoY | 23.6% | 16.9% |
| Net Profit YoY | — | 3.4% |
| EPS (diluted) | — | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $163.7M | $103.7M | ||
| Q3 25 | $154.3M | — | ||
| Q2 25 | $147.6M | — | ||
| Q1 25 | $136.3M | — | ||
| Q4 24 | $132.5M | — | ||
| Q3 24 | $129.1M | — | ||
| Q2 24 | $117.5M | — | ||
| Q1 24 | $110.3M | — |
| Q4 25 | $999.0K | $-30.5M | ||
| Q3 25 | $-8.8M | — | ||
| Q2 25 | $-18.4M | — | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-171.9M | — | ||
| Q2 24 | $-7.8M | — | ||
| Q1 24 | $-5.0M | — |
| Q4 25 | 69.8% | 52.0% | ||
| Q3 25 | 68.1% | — | ||
| Q2 25 | 68.6% | — | ||
| Q1 25 | 68.0% | — | ||
| Q4 24 | 66.8% | — | ||
| Q3 24 | 50.1% | — | ||
| Q2 24 | 68.5% | — | ||
| Q1 24 | 69.1% | — |
| Q4 25 | -3.2% | -31.7% | ||
| Q3 25 | -11.3% | — | ||
| Q2 25 | -21.8% | — | ||
| Q1 25 | -29.3% | — | ||
| Q4 24 | -35.8% | — | ||
| Q3 24 | -197.6% | — | ||
| Q2 24 | -9.8% | — | ||
| Q1 24 | -4.9% | — |
| Q4 25 | 0.6% | -29.4% | ||
| Q3 25 | -5.7% | — | ||
| Q2 25 | -12.5% | — | ||
| Q1 25 | -17.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -133.1% | — | ||
| Q2 24 | -6.7% | — | ||
| Q1 24 | -4.5% | — |
| Q4 25 | — | $-0.50 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.06 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $693.6M | $197.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $504.7M | $456.1M |
| Total Assets | $1.0B | $638.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $693.6M | $197.9M | ||
| Q3 25 | $653.9M | — | ||
| Q2 25 | $652.1M | — | ||
| Q1 25 | $593.9M | — | ||
| Q4 24 | $544.2M | — | ||
| Q3 24 | $495.5M | — | ||
| Q2 24 | $140.5M | — | ||
| Q1 24 | — | — |
| Q4 25 | $504.7M | $456.1M | ||
| Q3 25 | $472.1M | — | ||
| Q2 25 | $458.2M | — | ||
| Q1 25 | $412.9M | — | ||
| Q4 24 | $386.2M | — | ||
| Q3 24 | $458.2M | — | ||
| Q2 24 | $97.5M | — | ||
| Q1 24 | $102.5M | — |
| Q4 25 | $1.0B | $638.1M | ||
| Q3 25 | $949.4M | — | ||
| Q2 25 | $910.5M | — | ||
| Q1 25 | $867.3M | — | ||
| Q4 24 | $823.2M | — | ||
| Q3 24 | $750.1M | — | ||
| Q2 24 | $379.7M | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $25.8M | $-24.8M |
| Free Cash FlowOCF − Capex | $25.6M | $-34.8M |
| FCF MarginFCF / Revenue | 15.7% | -33.5% |
| Capex IntensityCapex / Revenue | 0.1% | 9.6% |
| Cash ConversionOCF / Net Profit | 25.79× | — |
| TTM Free Cash FlowTrailing 4 quarters | $95.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.8M | $-24.8M | ||
| Q3 25 | $5.0M | — | ||
| Q2 25 | $29.7M | — | ||
| Q1 25 | $36.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.4M | — | ||
| Q2 24 | $8.1M | — | ||
| Q1 24 | $25.5M | — |
| Q4 25 | $25.6M | $-34.8M | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $29.4M | — | ||
| Q1 25 | $35.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $7.7M | — | ||
| Q1 24 | $24.9M | — |
| Q4 25 | 15.7% | -33.5% | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 19.9% | — | ||
| Q1 25 | 26.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 6.6% | — | ||
| Q1 24 | 22.5% | — |
| Q4 25 | 0.1% | 9.6% | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | 25.79× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
TWST
| Industrial Chemicals | $37.2M | 36% |
| Diagnostics | $35.3M | 34% |
| Food Or Agriculture | $12.8M | 12% |
| Academic Research | $12.2M | 12% |
| Health Care | $6.1M | 6% |
